|

Orelabrutinib Placebo Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • InnoCare Pharma Inc.1
  • Beijing InnoCare Pharma Tech Co., Ltd.1

Indications

  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1
  • Mantle Cell Lymphoma1
  • Cancer1

Other2 trials

A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.